Alkermes (ALKS) Current Taxes (2015 - 2016)
Alkermes (ALKS) posted quarterly Current Taxes of $899000.0 for Q4 2016, down 24.77% year-over-year from $1.2 million in Q1 2016, and up 17.36% quarter-over-quarter from $766000.0 in Q3 2016.
Alkermes (ALKS) Current Taxes (2015 - 2016) Analysis & Trends
Alkermes (ALKS) has reported Current Taxes for 2 consecutive years, with $899000.0 the latest figure, recorded in Q4 2016.
- In Q4 2016, Current Taxes fell 24.77% year-over-year to $899000.0; the TTM figure through Dec 2016 stood at $899000.0 (down 24.77% YoY), while the FY2016 annual figure was $899000.0, down 24.77% from the prior year.
- Current Taxes rose to $899000.0 in Q4 2016 per ALKS's latest filing, from $766000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $20.6 million in Q1 2016 and bottomed at $766000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 46.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 899,000.00 |
| Sep 30, 2016 | 766,000.00 |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 20.63 Mn |
| Dec 31, 2015 | 1.20 Mn |